A detailed history of Black Rock Inc. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Black Rock Inc. holds 6,738,735 shares of WVE stock, worth $88.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,738,735
Previous 6,375,250 5.7%
Holding current value
$88.4 Million
Previous $39.3 Million 14.51%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.38 - $6.48 $1.59 Million - $2.36 Million
363,485 Added 5.7%
6,738,735 $33.6 Million
Q1 2024

May 10, 2024

BUY
$3.54 - $6.84 $3.57 Million - $6.9 Million
1,008,962 Added 18.8%
6,375,250 $39.3 Million
Q4 2023

Feb 13, 2024

BUY
$4.16 - $6.87 $2.09 Million - $3.45 Million
502,522 Added 10.33%
5,366,288 $27.1 Million
Q3 2023

Nov 13, 2023

BUY
$3.56 - $5.75 $851,235 - $1.37 Million
239,111 Added 5.17%
4,863,766 $28 Million
Q2 2023

Aug 11, 2023

BUY
$3.51 - $4.69 $11.3 Million - $15.1 Million
3,213,732 Added 227.78%
4,624,655 $16.8 Million
Q1 2023

May 12, 2023

SELL
$3.58 - $6.3 $258,203 - $454,381
-72,124 Reduced 4.86%
1,410,923 $6.11 Million
Q4 2022

Feb 13, 2023

BUY
$3.18 - $7.0 $391,693 - $862,218
123,174 Added 9.06%
1,483,047 $10.4 Million
Q3 2022

Nov 14, 2022

BUY
$2.37 - $4.28 $57,794 - $104,372
24,386 Added 1.83%
1,359,873 $4.91 Million
Q2 2022

Aug 12, 2022

SELL
$1.23 - $3.25 $1.97 Million - $5.21 Million
-1,602,299 Reduced 54.54%
1,335,487 $4.34 Million
Q1 2022

May 12, 2022

BUY
$2.0 - $3.28 $86,846 - $142,427
43,423 Added 1.5%
2,937,786 $5.88 Million
Q4 2021

Feb 10, 2022

BUY
$3.14 - $5.15 $177,648 - $291,366
56,576 Added 1.99%
2,894,363 $9.09 Million
Q3 2021

Nov 09, 2021

SELL
$4.89 - $7.12 $7,569 - $11,021
-1,548 Reduced 0.05%
2,837,787 $13.9 Million
Q2 2021

Aug 11, 2021

BUY
$5.65 - $7.47 $16 Million - $21.2 Million
2,839,335 New
2,839,335 $18.9 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.14B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.